Page last updated: 2024-08-21

alpha-aminopyridine and Atrophy

alpha-aminopyridine has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, H; Hayashi, H; Ishiki, A; Kawakatsu, S; Kobayashi, R; Okamura, N; Otani, K1
Jung, SH; Ryu, WS; Sun, X; Yang, BS1

Reviews

1 review(s) available for alpha-aminopyridine and Atrophy

ArticleYear
[
    BMC neurology, 2018, Aug-08, Volume: 18, Issue:1

    Topics: Aged; Aminopyridines; Aniline Compounds; Aphasia, Primary Progressive; Atrophy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Quinolines; Semantics; Temporal Lobe; Thiazoles; Tomography, Emission-Computed, Single-Photon

2018

Other Studies

1 other study(ies) available for alpha-aminopyridine and Atrophy

ArticleYear
Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
    The British journal of dermatology, 2013, Volume: 168, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminopyridines; Animals; Anti-Inflammatory Agents; Atrophy; Dasatinib; Dermatitis, Allergic Contact; Drug Evaluation; Female; Mice; Mice, Hairless; Mice, Inbred BALB C; Oxazolone; Protein Kinase Inhibitors; Pyrimidines; Skin; Thiazoles; Thiophenes

2013